Skip to content
Press Releases
Filter Releases
 
Press Releases
Jun 28, 2013
South San Francisco, Calif. --- June 28, 2013 --- Veracyte, Inc., a molecular diagnostics company in the field of molecular cytology, today announced the completion of the final tranche of its $28 million Series C financing. The financing included GE Ventures as a new investor, as well as existing investors...
PDF
Apr 17, 2013
South San Francisco, Calif. --- April 17, 2013 --- A new study shows that the number of patients with thyroid nodules who undergo surgery – increasingly to remove all, rather than part, of their thyroid – has risen by 31% over five years, Veracyte announced today. The findings suggest that growi...
PDF
Apr 12, 2013
South San Francisco, Calif. --- April 12, 2013 --- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced the appointment of Shelly D. Guyer as chief financial officer. “We are delighted to welcome Shelly Guyer to the Veracyte team,...
PDF
Mar 12, 2013
South San Francisco, Calif. --- March 12, 2013 --- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced new study findings showing that when BRAF V600E mutation testing was conducted on ambiguous thyroid nodule samples that were subsequently cl...
PDF
Mar 8, 2013
South San Francisco, Calif. --- March 8, 2013 --- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced that UnitedHealthcare, one of the nation’s largest private health insurers, has issued a positive medical coverage policy for the Afi...
PDF
Feb 15, 2013
South San Francisco, Calif. --- February 15, 2013 --- Veracyte, Inc. today announced that a new review article published in PLOS Currents: Evidence on Genomic Tests concludes that published studies and independent assessments and reviews...
PDF
Jan 7, 2013
South San Francisco, Calif. --- January 7, 2013 --- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced that, for the first time, molecular testing is now included in the National Comprehensive Cancer Network Clinical Practice Guidelines in ...
PDF
Oct 22, 2012
South San Francisco, Calif. --- October 22, 2012 --- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced that study findings demonstrating the analytic validity of its Afirma® Gene Expression Classifier have been published online in the ...
PDF
Aug 29, 2012
South San Francisco, Calif. and Cambridge, Mass. --- August 29, 2012 --- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced that the New York Sta...
PDF
Jul 17, 2012
South San Francisco, Calif. and Cambridge, Mass. — July 17, 2012 — Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced the publica...
PDF
Page: First Previous
...
Next Last